Visa has announced its acquisition of BioCatch, an Israeli behavioral biometrics company, for $2.4 billion in cash.

Context

This acquisition is part of Visa's strategy to enhance its cybersecurity offerings and strengthen its position in the digital payments landscape.S2

Key points

• Visa is acquiring BioCatch from funds advised by Permira.S1

• The deal is valued at $2.4 billion in cash.S1

• BioCatch specializes in behavioral biometrics technology.S2

• The acquisition aims to bolster Visa's cybersecurity capabilities.S2

• Visa's move reflects a growing focus on digital security in financial transactions.S2

• BioCatch's technology helps in fraud detection and prevention.S2

• The deal is expected to close in the coming months, pending regulatory approvals.S1

• Visa continues to expand its portfolio through strategic acquisitions.S1

Why it matters

• Enhancing cybersecurity is critical as digital payment fraud increases.S2

• The acquisition positions Visa to better compete in the evolving fintech landscape.S2

What to watch

• Monitor regulatory responses to the acquisition.S1

• Watch for updates on how Visa integrates BioCatch's technology.S2